Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. Viewpoint Sep 2022 Why the Post-Roe Era Requires Protecting Conscientious Provision as We Protect Conscientious Refusal in Health Care Isa Ryan, MD, MSc, Ashish Premkumar, MD, and Katie Watson, JD Extraordinary changes to the legal landscape of abortion care require reevaluating health professionals’ appropriation of conscience. AMA J Ethics. 2022;24(9):E906-912. doi: 10.1001/amajethics.2022.906. Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
Viewpoint Sep 2022 Why the Post-Roe Era Requires Protecting Conscientious Provision as We Protect Conscientious Refusal in Health Care Isa Ryan, MD, MSc, Ashish Premkumar, MD, and Katie Watson, JD Extraordinary changes to the legal landscape of abortion care require reevaluating health professionals’ appropriation of conscience. AMA J Ethics. 2022;24(9):E906-912. doi: 10.1001/amajethics.2022.906.
Viewpoint Dec 2010 Drugs, Doctors, Profits, and Conflicts of Interest: Avastin versus Lucentis Stephen R. Kaufman, MD Deciding whether to recommend Avastin or Lucentis raises ethical issues. Should the public health consequences of using a far more expensive drug trump what the doctor thinks is best for the individual patient? Virtual Mentor. 2010;12(12):955-958. doi: 10.1001/virtualmentor.2010.12.12.oped1-1012.